Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
The EMBO Journal (2011) 30, 4248–4260 www.embojournal.org |& 2011 European Molecular Biology Organization | All Rights Reserved 0261-4189/11 THE EMBO JOURNAL LPA-producing enzyme PA-PLA1a regulates hair follicle development by modulating EGFR signalling Asuka Inoue1,2,*, Naoaki Arima1, Jun Ishiguro1, Glenn D Prestwich3, Hiroyuki Arai2,4 and Junken Aoki1,5,* 1 Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan, 2 Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan, 3Department of Medicinal Chemistry, The University of Utah, Salt Lake City, UT, USA, 4 CREST, Japan Science and Technology Corporation, Tokyo, Japan and 5 PRESTO, Japan Science and Technology Corporation, Tokyo, Japan Recent genetic studies of human hair disorders have suggested a critical role of lysophosphatidic acid (LPA) signalling in hair follicle development, mediated by an LPAproducing enzyme, phosphatidic acid-selective phospholipase A1a (PA-PLA1a, also known as LIPH), and a recently identified LPA receptor, P2Y5 (also known as LPA6). However, the underlying molecular mechanism is unknown. Here, we show that epidermal growth factor receptor (EGFR) signalling underlies LPA-induced hair follicle development. PA-PLA1a-deficient mice generated in this study exhibited wavy hairs due to the aberrant formation of the inner root sheath (IRS) in hair follicles, which resembled mutant mice defective in tumour necrosis factor a converting enzyme (TACE), transforming growth factor a (TGFa) and EGFR. PA-PLA1a was co-localized with TACE, TGFa and tyrosine-phosphorylated EGFR in the IRS. In PAPLA1a-deficient hair follicles, cleaved TGFa and tyrosinephosphorylated EGFR, as well as LPA, were significantly reduced. LPA, P2Y5 agonists and recombinant PA-PLA1a enzyme induced P2Y5- and TACE-mediated ectodomain shedding of TGFa through G12/13 pathway and consequent EGFR transactivation in vitro. These data demonstrate that a PA-PLA1a–LPA–P2Y5 axis regulates differentiation and maturation of hair follicles via a TACE–TGFa–EGFR pathway, thus underscoring the physiological importance of LPAinduced EGFR transactivation. The EMBO Journal (2011) 30, 4248–4260. doi:10.1038/ emboj.2011.296; Published online 19 August 2011 Subject Categories: signal transduction; development Keywords: EGFR transactivation; hair follicle; lysophosphatidic acid (LPA); transforming growth factor a (TGFa); tumour necrosis factor a converting enzyme (TACE) *Corresponding authors. A Inoue or J Aoki, Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Aobayama, Aoba-ku, Sendai 980-8578, Japan. Tel.: þ 81 22 795 6861; Fax: þ 81 22 795 6859; E-mail: [email protected] or Tel.: þ 81 22 795 6860; Fax: þ 81 22 795 6859; E-mail: [email protected] Received: 20 May 2011; accepted: 20 July 2011; published online: 19 August 2011 4248 The EMBO Journal VOL 30 | NO 20 | 2011 Introduction Lysophosphatidic acid (1- or 2-acyl-lysophosphatidic acid; LPA) is a bioactive lipid with numerous biological functions. LPA exerts most of its functions through G protein-coupled receptors (GPCRs) (Anliker and Chun, 2004; Moolenaar et al, 2004). So far, six LPA-specific GPCRs belonging to either the endothelial cell differentiation gene family (LPA1,2,3) or P2Y family (LPA4,5,6) have been identified (Anliker and Chun, 2004; Ishii et al, 2009; Chun et al, 2010). These LPA receptors, by coupling with different G proteins and having distinct expression patterns, play important roles in various physiological and pathophysiological conditions (Aoki et al, 2008; Skoura and Hla, 2009; Choi et al, 2010). Extracellular LPA production occurs at least in two distinct pathways (Aoki et al, 2008). In biological fluids such as serum, a soluble enzyme called autotaxin (ATX) hydrolyzes lysophospholipids with its lysophospholipase D activity and produces LPA (Aoki et al, 2002). In cellular membranes, membrane-associated enzymes called phosphatidic acid (PA)-selective phospholipase A1a (PA-PLA1a, also known as mPA-PLA1a and LIPH) (Sonoda et al, 2002) and PA-PLA1b (also known as mPA-PLA1b and LIPI) (Hiramatsu et al, 2003) hydrolyze PA and produce 2-acyl-LPA (with acyl chain at the sn-2 position of glycerol). While the functions of ATX have been well characterized in angiogenesis (Tanaka et al, 2006; van Meeteren et al, 2006), brain development (Koike et al, 2009), cancer metastasis (Mills and Moolenaar, 2003) and lymphocyte traffic (Kanda et al, 2008), the physiological roles of the latter enzymes have remained unclear until recently. Kazantseva et al (2006) reported that homozygous mutation in the PA-PLA1a gene was found to cause a congenital hair disorder in human (termed LAH2). Affected individuals were characterized by hereditary woolly hair and/or sparse hair (Kazantseva et al, 2006; Shimomura et al, 2009). Interestingly, homozygous mutations in the P2Y5 (also known as P2RY5) gene were found to be responsible for another congenital hair disorder (termed LAH3) (Pasternack et al, 2008; Shimomura et al, 2008). The P2Y5 gene encodes an orphan GPCR sharing 56% amino-acid identity with LPA4, which is presently the closest known homologue of P2Y5. Accordingly, Yanagida et al (2009) showed that LPA behaved as a ligand for P2Y5 and thus named P2Y5 as LPA6. Thus, we postulated that PA-PLA1a hydrolyzes PA on the plasma membrane and provides 2-acyl-LPA for P2Y5, which leads to hair follicle formation (Figure 1A). The idea that PA-PLA1a and P2Y5 have cooperative roles in hair follicle formation is also supported by observations that (i) both PA-PLA1a and P2Y5 are highly expressed in hair follicles, especially in epithelial cells (Kazantseva et al, 2006; Shimomura et al, 2008) and (ii) affected individuals with LAH2 and LAH3 are clinically indistinguishable. It is likely that PA-PLA1a activates P2Y5 through production of LPA. However, how LPA-P2Y5 signalling regulates hair follicle formation remains to be determined. In this & 2011 European Molecular Biology Organization LPA-induced EGFR transactivation in hair follicles A Inoue et al B A C +/+ +/+ –/– –/– Phosphatidic acid (PA) PA-PLA1α Lysophosphatidic acid (LPA) P2Y5 Epithelial cell D E +/+ –/– +/+ Hair formation F +/+ –/– –/– Figure 1 Wavy hair phenotype of PA-PLA1a/ mice. (A) Scheme of PA-PLA1a and P2Y5 pathway in hair formation, proposed by human genetic studies. Genetically, hereditary mutations in the PA-PLA1a gene (Kazantseva et al, 2006; Shimomura et al, 2009) and the P2Y5 gene (Pasternack et al, 2008; Shimomura et al, 2008) cause clinically indistinguishable hair disorders in human. Biochemically, PA-PLA1a is capable of hydrolyzing PA (Sonoda et al, 2002) and P2Y5 responds to LPA (Yanagida et al, 2009). It remained unclear whether LPA was actually involved in this pathway and, if so, how LPA signalling regulated hair formation. (B, C) Hair coats (B) and vibrissa hairs (C) of WT ( þ / þ ) and PA-PLA1a/ (/) mice on postnatal day (P) 25. Note that hair coat of a WT mouse shows shiny appearance, whereas hair coat of a PAPLA1a/ mouse shows wavy and matted appearance. (D–F) Pelage hairs were observed under an optical microscope (D, E) and a scanning electron microscope (E). Compared with WT hairs, all of four hair types of PA-PLA1a / pelage hairs (inset from top: guard, awl, auchene and zigzag) show waviness (D). Note that PA-PLA1a/ hair shows disorganized medulla and irregular melanin piles (E) and wavy cuticle (F). Scale bars, 2 cm (B), 500 mm (D), 20 mm (E) and 5 mm (F). study, to obtain clues about the molecular mechanism underlying LPA-mediated hair follicle formation, we generated and analysed PA-PLA1a-deficient (PA-PLA1a/) mice and found that epidermal growth factor receptor (EGFR) signalling underlies LPA-mediated hair follicle formation. Results PA-PLA1a/ mice show wavy hair phenotype To investigate the effect of PA-PLA1a deletion in mice, we disrupted the PA-PLA1a gene of murine embryonic stem cells by replacing exon 3, which encodes the active residue Ser154, with a neomycin resistance cassette (Supplementary Figure S1A). Deletion of exon 3 resulted in a frameshift mutation and no immunoreactive PA-PLA1a protein (Supplementary Figure S1C; Figures 3F and 4D). PA-PLA1a/ mice were born with the expected Mendelian ratio from an intercross of heterozygous parents ( þ / þ : þ /:/ ¼ 86:205:84). PA-PLA1a/ mice were distinguishable from wild-type (WT) or heterozygous littermates by aberrant hair characteristics including wavy vibrissa hair and a matted coat (Figure 1B and C). Pelage hairs from PA-PLA1a/ mice showed waviness, disorganized medulla, irregular melanin piles and wavy cuticles (Figure 1D–F). The hair abnormalities were observed in all PA-PLA1a/ mice (4300 animals observed) and, more importantly, in two PA-PLA1a/ lines derived from independent ES clones (clones 1D-A1 and 4C-D3). Thus, in the following experiments, only the line derived from clone 1D-A1 was examined. The wavy hair phenotype was most apparent from 1 to 4 weeks of age and & 2011 European Molecular Biology Organization became less severe after the start of the anagen (growth) phase of the first hair cycle. Of note, these hair abnormalities of PA-PLA1a/ mice resembled those of mutant mice defective in keratin genes specific to the inner root sheath (IRS), the layer surrounding the hair shaft (Figure 3E), of hair follicles (Kikkawa et al, 2003; Peters et al, 2003; Tanaka et al, 2007), as well as transforming growth factor a (TGFa)-related genes including TNFa-converting enzyme (TACE, also known as ADAM17) (Peschon et al, 1998), TGFa (Luetteke et al, 1993; Mann et al, 1993) and EGFR (Luetteke et al, 1994), as discussed below. Unlike humans with PA-PLA1a-null mutations, PA-PLA1a/ mice did not seem to develop alopecia. Besides hair abnormalities, we could not find any difference between PA-PLA1a/ mice and WT or heterozygous littermates such as fertility or growth rate under normal conditions (data not shown). Reduced 2-acyl-LPA in PA-PLA1a/ mice LPA detected in vivo consists of a mixture of LPA species with various fatty acids attached to either the sn-1 (1-acylLPA) or sn-2 (2-acyl-LPA) position of the glycerol backbone. To examine which LPA species, if any, are produced by PA-PLA1a in skin and hair follicles, which generate hair shafts, we analysed LPA species of tissue extracts using a newly developed liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. LPA ions were selectively detected by the selective reaction monitoring mode (e.g. m/z 409.3 for the negatively charged parent ion of 16:0-LPA and m/z 153.0 for the fragment ion of 16:0-LPA). Consistent with a previous reversed-phase LC condition (Creer and The EMBO Journal VOL 30 | NO 20 | 2011 4249 LPA-induced EGFR transactivation in hair follicles A Inoue et al phosphatidylglycerol), LPI (lysophosphatidylinositol), LPS (lysophosphatidylserine) and S1P (sphingosine 1-phosphate) were unchanged in both isolated vibrissa hair follicles and dorsal skin of PA-PLA1a/ mice (Figure 2C; Supplementary Figure S2B and C and data not shown), confirming that LPA was specifically decreased in PA-PLA1a/ mice. These data demonstrate that PA-PLA1a produces LPA, especially 2-acylLPA with unsaturated fatty acids, in hair follicle. Gross, 1985), we observed two separate peaks corresponding to the 2-acyl isomer (first elution) and the 1-acyl isomer (second elution) (Supplementary Figure S2A). Among eight LPA species examined, five of six unsaturated LPA species (18:2, 18:1, 20:5, 20:4 and 22:6) were significantly reduced in both isolated vibrissa hair follicles and dorsal skin of PAPLA1a/ mice (Figure 2A and data not shown). Notably, in hair follicle of PA-PLA1a/ mice, the six unsaturated LPA species were reduced by 490%, whereas saturated LPA species were unchanged (18:0) or slightly decreased (16:0) (Figure 2A). When 1-acyl isomer and 2-acyl isomer of LPA were separately quantified, 2-acyl-LPA in three predominant LPA species (16:0, 18:2 and 18:1) were significantly lowered in PA-PLA1a/ hair follicles, whereas 1-acyl-LPA remained largely unchanged (Figure 2B). These data are consistent with the asymmetry of fatty acid composition of phospholipids in which saturated fatty acid and (poly)unsaturated fatty acid are generally attached at the sn-1 and sn-2 positions of the glycerol backbone, respectively. The levels of six other lysophospholipids including LPC (lysophosphatidylcholine), LPE (lysophosphatidylethanolamine), LPG (lyso- Impaired IRS formation in PA-PLA1a/ hair follicles Among hair follicle layer-specific keratins, wavy hair phenotype appears only in mice with mutations for IRS-specific keratins (Krt25, Krt27 and Krt71) (Kikkawa et al, 2003; Peters et al, 2003; Tanaka et al, 2007). Thus, the irregular hair in PA-PLA1a/ mice occurred most likely due to defects in the formation of the IRS. Indeed, histological analysis of cross sections of vibrissa hair follicles with haematoxylin and eosin (HE) showed that the IRS of PA-PLA1a/ hair follicles, compared with that of WT hair follicles, was irregularly structured (Figure 3A). Other hair follicle structures such as the outer root sheath (ORS) and the dermal papilla appeared Relative peak area A 0.07 +/+ 0.05 0.04 0.03 0.02 0.01 ** 0 16:0 *** 18:2 B Relative peak area –/– 0.06 0.06 0.05 0.04 0.03 0.02 0.01 0 *** NS 18:1 18:0 +/+ –/– ** 20:4 ** 20:5 0.01 Relative peak area * 22:5 NS 0.008 0.006 NS 0.004 ** 16:0 *** 18:2 *** 18:1 NS NS 0.002 0 18:0 16:0 2-acyl-LPA C ** 22:6 18:1 18:0 1-acyl-LPA +/+ 2 ** 18:2 –/– 1.5 1 0.5 0 ** LPA LPC LPE LPG LPI LPS S1P Figure 2 LPA is lowered in PA-PLA1a/ hair follicles. (A) Relative abundance of eight LPA species in vibrissa hair follicles. Lipids in vibrissa hair follicles from P15 WT ( þ / þ ) and PA-PLA1a/ (/) mice (during the hair growth phase) were extracted with methanol and analysed by an LC-MS/MS method. Peak areas of 1-acyl-LPA and 2-acyl-LPA were combined and normalized to the internal standard 17:0-LPA (n ¼ 8). Numbers in the x axis denote acyl chains that are attached to LPA. 16:0, palmitoyl; 18:2, linoleoyl; 18:1, oleoyl; 18:0, stearoyl; 20:5, eicosapentanoyl; 20:4, arachidonoyl; 22:6, docosahexanoyl; 22:5, docosapentaenoyl. (B) Same as (A), but 2-acyl-LPA and 1-acyl-LPA in (A) were separately quantified. (C) LC-MS/MS analysis of lysophospholipids in vibrissa hair follicles. Except for S1P, eight acyl moieties of each lysophospholipid were monitored and the sum of the peak areas was used for quantification (see Supplementary Figure S2 for details). The mean value in þ / þ sample was set at 1 (n ¼ 8). Asterisks, *Po0.05, **Po0.01, ***Po0.001 versus þ / þ . NS, not significant difference between þ / þ and /. 4250 The EMBO Journal VOL 30 | NO 20 | 2011 & 2011 European Molecular Biology Organization LPA-induced EGFR transactivation in hair follicles A Inoue et al Henle’s layer +/+ I –/– α 1 LA α A1 PL I P PA P DA PA P DA 5 Cortex Medula F Hair cuticle IRS cuticle Huxley’s layer Hair shaft K8 K7 5 Tr ic ho hy al in K7 2 K1 7 ORS –/– IRS Henle’s layer +/+ A Companion layer E K71 Huxley’s layer IRS cuticle Relative mRNA expression B 1.6 1.4 1.2 1 0.8 0.6 0.4 0.2 0 +/+ G * Gata3 K ** Tchh Krt71 Krt72 IRS K85 +/+ –/– 72 ** ** Krt85 Hair shaft C –/– K71 +/+ –/– Krt75 Companion layer K72 +/+ –/– Krt17 ORS LA P P A- α in al 1 hy Tr o ich e M g er H 75 K LA P A- P α in al 1 hy Tr o ich ge er M Vim Dermal sheath K75 +/+ –/– Keratin α-tubulin +/+ –/– * ** K85 Hair shaft K71 K72 IRS K75 HE Relative protein expression 1.4 1.2 1 0.8 0.6 0.4 0.2 0 In situ hybridization I D Companion layer Figure 3 Impaired IRS formation in PA-PLA1a/ hair follicles. (A) HE staining of vibrissa hair follicles. Magnified views of the boxed areas are shown in the bottom panels. The arrow indicates the discontinuous Henle’s layer in a PA-PLA1a/ vibrissa hair follicle. Scale bars, 20 mm (top) and 5 mm (bottom) (B) Quantitative RT–PCR (qRT–PCR) analysis of hair follicle layer-specific markers in P4 dorsal hair follicles. The number of transcripts was normalized to the housekeeping gene, Gapdh, in the same sample and the mean value in þ / þ sample was set at 1 (n ¼ 4). (C, D) Immunoblot analysis of hair follicle layer-specific markers in P10 dorsal skin and densitometric quantification. The marker intensity was normalized to a-tubulin in the same sample and the mean value in þ / þ sample was set at 1 (n ¼ 4). (E) A schematic illustration of hair follicle layers and marker expressions in follicular layers. (F–H) Immunofluorescent detection of PA-PLA1a in dorsal hair follicles. Nuclei were stained with DAPI. Specificity of anti-PA-PLA1a antibody was confirmed using PA-PLA1a/ hair follicle (F). K72 (G) and K75 (H) (detected with Alexa Fluor 647) were pseudo-coloured ‘blue.’ Magnified views of the boxed areas are shown in the bottom panels. The arrows indicate co-expression of PA-PLA1a with K72 (G) and K75 (H) in WT hair follicles. Scale bars, 20 mm (top) and 5 mm (bottom). (I) In situ hybridization of PA-PLA1a mRNA in P15 WT vibrissa hair follicles (upper panels, purple hybridization signal). A serial section was stained with HE (lower panels). No significant signals were detected using a sense probe (data not shown). Note that brown dots inside the hair cuticle in the middle panel are melanin granules, not a hybridization signal. Left panels, longitudinal sections of hair follicles; middle panels, enlarged images of the boxed areas in the left panels; right panels, cross sections of hair follicles. Arrows, IRS; arrowheads, hair cuticle. Scale bars represent 100 mm in left panels and 20 mm in middle and right panels. *Po0.05, **Po0.01 versus þ / þ . normal (Figure 3A and data not shown). The IRS consists of the three layers (Henle’s layer, Huxley’s layer and the IRS cuticle, from outermost to innermost; Figure 3E) and plays an important role in anchoring hair shaft and supporting of its development. In WT hair follicles, Henle’s layer was recognized by fully keratinized and continuous cells that were unstained by HE, and Huxley’s layer consisted of multiplelayered cells containing Eosin-positive trichohyalin granules (Figure 3A). In contrast, in PA-PLA1a/ hair follicles, Henle’s layer appeared to be discontinuous and Huxley’s layer protruded into the ORS (Figure 3A). We noticed, however, that the IRS length was not significantly different between the two genotypes (Supplementary Figure S3A–D), & 2011 European Molecular Biology Organization suggesting that the IRS in PA-PLA1a/ hair follicle, although morphologically deformed, could still undergo maturation/ keratinization processes. The hair cycle and epidermal structure were also unaffected in PA-PLA1a/ mice (data not shown). To confirm IRS malformation at the biochemical level, we next examined expressions of layer-specific marker genes. Quantitative RT–PCR revealed remarkable reductions in IRS markers (Krt71, Krt72 and Tchh encoding Keratin 71 (K71), K72, trichohyalin, respectively) (Langbein et al, 2003, 2006) as well as a slight reduction in a companion layer marker (Krt75) in PA-PLA1a/ hair follicles (Figure 3B). Expression levels of other hair follicle markers including hair shaft (Krt85), ORS (Krt17) or dermal sheath (Vim The EMBO Journal VOL 30 | NO 20 | 2011 4251 LPA-induced EGFR transactivation in hair follicles A Inoue et al encoding Vimentin) (Schweizer et al, 2007) were not different between the two genotypes (Figure 3B). Notably, the expression of an early IRS differentiation marker (Gata3) (Kaufman et al, 2003) was not affected in PA-PLA1a/ mice (Figure 3B), in agreement with the existence of IRS structures (Figure 3A). At the protein level, IRS markers (K71 and K72) were also significantly decreased in PA-PLA1a/ hair follicles whereas a hair shaft marker (K85) and a companion layer marker (K75) were not (Figure 3C and D). These data again suggest that, among the multiple layers in hair follicles, the IRS is specifically affected by disruption of PA-PLA1a, which may lead to impaired guidance and maturation of developing hair shafts, thus resulting in wavy hair formation. In situ localization of PA-PLA1a expression in the hair follicles was analysed by immunofluorescent staining and in situ mRNA hybridization techniques. Immunofluorescent staining detected the presence of PA-PLA1a protein in hair follicle epithelial cells (Figure 3F). The PA-PLA1a signals were not observed in PA-PLA1a/ hair follicles (Figure 3F), confirming the specificity of the anti-PA-PLA1a rat monoclonal antibody established in this study. We also performed double immunostaining using anti-PA-PLA1a and hair follicle layerspecific markers. An intense PA-PLA1a signal within the hair follicles was co-localized in two layers with an IRS cuticle marker (K72) and a companion layer marker (K75) (Figure 3G and H). The localization of PA-PLA1a was also confirmed by an in situ mRNA hybridization analysis, which showed that an intense mRNA signal in the IRS and a less intense signal in the companion layer (Figure 3I). This expression pattern was consistent with the observation that PA-PLA1a/ hair follicles exhibited aberrant IRS (Figure 3A–D), strongly suggesting that the primary defect in PA-PLA1a/ hair follicle is in the IRS. PA-PLA1a is co-expressed with TACE, TGFa and EGFR in hair follicles We noticed that the wavy hair phenotype of PA-PLA1a/ mice was similar to the phenotypes of TACE-deficient (Peschon et al, 1998), TACE mutant (known as woe) (Hassemer et al, 2010), TGFa-deficient, TGFa mutant (known as wa-1) (Luetteke et al, 1993; Mann et al, 1993) and EGFR mutant (known as wa-2) mice (Luetteke et al, 1994). TACE, a member of a disintegrin and metalloprotease (ADAM) family, is capable of cleaving a transmembrane proform of TGFa (Sahin et al, 2004), a process referred to as ectodomain shedding, and the subsequent binding of soluble TGFa to EGFR results in activation of EGFR, known as transactivation. Thus, the TACE–TGFa–EGFR pathway has been recognized as an important regulator of hair follicle development. The phenotypic resemblance of these mutant mice to PA-PLA1a/ mice led us to hypothesize that the TACE–TGFa–EGFR pathway is regulated by PA-PLA1a, most likely through production of LPA and the subsequent activation of P2Y5 in hair follicles. Immunofluorescent staining revealed that TACE, TGFa and the phosphorylated form of EGFR (p-EGFR; phosphorylated at Tyr1068, a critical site for autophosphorylation), were co-expressed with PA-PLA1a in the IRS, specifically in the IRS cuticle of the K72-positive layer (Figure 4A–C). We found that PA-PLA1a was upregulated during the growth (morphogenesis or anagen) phase of the hair cycle and downregulated during the regression (catagen) and resting (telogen) phases at both the protein and mRNA 4252 The EMBO Journal VOL 30 | NO 20 | 2011 levels (Figure 4D–F). The expression pattern of P2Y5 was also hair cycle dependent and was nearly identical to that of PA-PLA1a in both the developmental and adult stages (Figure 4F; Supplementary Figure S4), suggesting that both P2Y5 and PA-PLA1a have cooperative roles during the anagen phase. Our results are consistent with previous observations that TGFa and P2Y5 were expressed in the IRS (Luetteke et al, 1993; Shimomura et al, 2008). These data strongly support our hypothesis that PA-PLA1a and P2Y5 regulates hair follicle formation through the TACE–TGFa–EGFR pathway. Impaired TGFa-EGFR signalling in PA-PLA1a/ hair follicles To test this hypothesis, we first examined the level of TGFa in PA-PLA1a/ hair follicles. The soluble TGFa was significantly lower (by 61% reduction) in PA-PLA1a/ hair follicles than in WT hair follicles (Figure 4G), whereas TGFa mRNA expression and membrane-bound TGFa protein were not significantly different between the two genotypes (Supplementary Figure S5A and B). Immunofluorescent staining also showed no apparent differences in the TGFa expression patterns (Supplementary Figure S6B). Immunoprecipitation and immunoblot analyses of dorsal skin lysate revealed that tyrosine-phosphorylated EGFR (i.e. activated EGFR) was lowered in PA-PLA1a/ mice than in WT mice (Figure 4H and I). Immunofluorescent staining using an antibody against p-EGFR confirmed that p-EGFR signal in the IRS was reduced in PA-PLA1a/ hair follicles (Figure 4J). These results indicate that PA-PLA1a induces TGFa release and subsequent EGFR phosphorylation in vivo, which is required for the proper development of hair follicles. P2Y5 and TACE mediate LPA-induced TGFa release and EGFR transactivation in keratinocytes LPA and other GPCR agonists have been shown to induce transactivation of EGFR in various cell types in vitro (Daub et al, 1997). A critical step of EGFR transactivation is ADAMmediated ectodomain shedding of EGFR ligands such as TGFa and heparin-binding EGF-like growth factor (HB-EGF) (Peschon et al, 1998; Prenzel et al, 1999; Sahin et al, 2004). We first examined whether LPA induces TGFa release and EGFR transactivation in keratinocytes. When primary epidermal keratinocytes were treated with LPA (18:1), the cells released significant amounts of TGFa (Figure 5A), which was equivalent to the amount observed in cells treated with 12-Otetradecanolyphorbol-13-acetate (TPA) (Figure 5A), a wellestablished PKC-dependent ADAM activator. The LPA-induced TGFa release was completely blocked by pretreatment with a broad-spectrum metalloprotease inhibitor, SDZ 242– 484 (Kottirsch et al, 2002) (Figure 5A). Among the LPA species tested, LPA (20:4) was the most potent in inducing TGFa release in keratinocytes (Figure 5B). Interestingly, we found that LPA species that were abundantly present in hair follicles (16:0, 18:1 and 20:4) (Figure 2A) had higher ability to induce TGFa release (Figure 5B). In the primary keratinocytes, LPA also induced an increase in the level of phosphorylated EGFR at Tyr1068 (p-EGFR) as well as phosphorylated ERK1/2 (p-ERK1/2), one of the downstream targets of EGFR (Figure 5C). Both p-EGFR and p-ERK were attenuated by pretreatment with SDZ 242–484 or an EGFR inhibitor, AG1478. These in vitro studies clearly demonstrate & 2011 European Molecular Biology Organization LPA-induced EGFR transactivation in hair follicles A Inoue et al A E P8 +/+ PA-PLA1α 50 - TGFα (ng/mg protein) * 50 - α-tubulin 50 - G 2 P2Y5 R = 0.814 PA-PLA1α 1.4 (n = 58) 1.2 1 0.8 0.6 PA-PLA1α 0.4 0.2 α-tubulin 0 Age 0 3 7 10 14 17 19 21 24 28 56 (Postnatal day) Morph Cat Tel Ana Tel Mr (K) 75 - –/– 75 - * F 50 - H 0.25 +/+ M r (K) –/– 0.2 IP: p-Tyr 0.15 0.1 * 150 - * 250 0.05 Input 0 +/+ –/– Soluble fraction J +/+ I 250 - 150 - Tyrosine-phosphorylated EGFR Mr (K) C Relative mRNA expression D B 1.2 1 * 0.8 0.6 –/– 0.4 0.2 0 +/+ –/– IB: EGFR Figure 4 PA-PLA1a is co-expressed with TACE, TGFa and p-EGFR in hair follicles and EGFR signalling is reduced in PA-PLA1a/ mice. (A–C) Immunofluorescent staining of PA-PLA1a with TACE (A), TGFa (B) and phosphorylated form of EGFR (p-EGFR) at Tyr1068 (C) in WT dorsal hair follicles. The arrows indicate co-expression of PA-PLA1a with each protein. Nuclei were stained with DAPI. Magnified views of the boxed areas are shown in the bottom panels. (D) Immunoblot analysis of PA-PLA1a in dorsal skin lysate. Lysate of skin from P8 WT ( þ / þ ) and PAPLA1a/ (/) mice was subjected to immunoblot using anti-PA-PLA1a antibody. The membrane was stripped and reprobed with anti-atubulin antibody as a loading control. The arrow and asterisk denote PA-PLA1a and non-specific bands, respectively. (E) Hair cycle-dependent expression of PA-PLA1a in dorsal skin. Skin specimens at different hair cycle stages were analysed by immunoblot as described above. Note that first hair cycle starts with catagen (P17). Morph, morphogenesis; Cat, catagen (regression); Tel, telogen (resting); Ana, anagen (growth). (F) qRT–PCR analysis of hair cycle-dependent expression of PA-PLA1a and P2Y5 mRNA in WT dorsal skin. The number of transcripts was normalized to Gapdh and the maximal value of each gene was set at 1 (n ¼ 3–5). R2, squared correlation coefficient between PA-PLA1a level and P2Y5 level. (G) Soluble TGFa level in vibrissa hair follicles from WT and PA-PLA1a/ mice. Lysate of vibrissa hair follicles during the growth phase were ultracentrifuged and the supernatants were subjected to TGFa sandwich ELISA. Amount of soluble TGFa was normalized to total protein in the same sample determined by the BCA method (mean±s.e.m.; n ¼ 4). (H) p-EGFR level in dorsal skin. Tyrosinephosphorylated proteins were immunoprecipitated from skin lysate during the hair growth phase using anti-phosphotyrosine (p-Tyr) monoclonal antibody (PY20). The immunoprecipitates (IP) and aliquots of total dorsal skin lysate (Input) were subjected to immunoblot with anti-EGFR antibody. The arrow and asterisk indicate bands corresponding to p-EGFR and IgG, respectively. (I) Densitometric analysis of p-EGFR in (H). The IP intensity was normalized to the input intensity in the same sample and the mean value in þ / þ sample was set at 1 (mean±s.e.m.; n ¼ 4). (J) Immunofluorescent staining of p-EGFR at Tyr1068 and K72 in WT and PA-PLA1a/ hair follicles. Nuclei were stained with DAPI. Scale bars represent 50 mm (A–C, upper panels), 5 mm (A–C, bottom panels) and 20 mm (J). *Po0.05 versus þ / þ . that LPA transactivates EGFR through ADAMs, which consequently leads to activation of ERK. We further examined whether P2Y5 and TACE were involved in the process of LPA-induced TGFa release in keratinocytes. Quantitative RT–PCR analysis showed that, among the six LPA receptors, P2Y5 was most abundantly expressed in both mouse primary epidermal keratinocytes and human HaCaT keratinocytes. In addition, the expression patterns of LPA receptors in the epidermal keratinocytes and HaCaT cells were nearly identical to those in mouse hair follicles (Figure 5D). To assess the involvement of P2Y5 and TACE in TGFa release, we used RNA interference to knockdown endogenous P2Y5 and TACE in HaCaT cells. Small interfering & 2011 European Molecular Biology Organization RNA (siRNA)-mediated knockdown of P2Y5 attenuated the LPA-induced, but not the TPA-induced, TGFa release, whereas knockdown of TACE, which was confirmed by immunoblot analysis (Figure 5E), almost completely inhibited both LPA-induced and TPA-induced TGFa release (Figure 5F). Furthermore, the P2Y5 agonists (XY31, XY36 and OMPT) identified in this study (Supplementary Figure S9A and B) induced TGFa release from both primary keratinocytes and HaCaT cells (Figure 5G and H). Notably, a strong correlation was found between the P2Y5-agonistic activity (Supplementary Figure S9B) and TGFa-releasing activity (Figure 5G and H) of these LPA analogues. Taken together, these data demonstrate that P2Y5 and TACE mediate LPAThe EMBO Journal VOL 30 | NO 20 | 2011 4253 LPA-induced EGFR transactivation in hair follicles A Inoue et al B ** *** 20 ** 15 10 5 0 LPA (μM) TPA – – 1 – 10 – – + – – 10 – – + SDZ 242–484 – – – – + + + D 35 30 25 20 15 10 5 0 1.2 HaCaT cells 0.8 TACE 0.6 0.4 α-tubulin 0.2 HaCaT cells 0 LPA2 LPA3 LPA4 LPA5 H TGFα (pg/ml) 30 20 10 P2Y5 10 – – + – – 1 – 10 – – + 1 – 10 – – + 20:4 ERK1/2 F Control siRNA P2Y5 siRNA TACE siRNA *** *** 40 30 *** *** ** 20 10 0 Vehicle LPA TPA 15 10 5 PT 0 T1 M O 36 31 XY 28 XY 0 PT M O 36 T1 31 XY A 28 XY XY LP Primary keratinocytes A 0 0 XY TGFα (pg/ml) 18:0 LPA 1 LPA1 1 – AG1478 – – p-EGFR 18:1 Vehicle LP Relative mRNA expression 1.4 – – SDZ 242–484 p-ERK1/2 16:0 E Primary keratinocyte Vehicle EGFR Hair follicle G ** * Pretreatment LPA (μM) EGF ** Control siRNA 25 TGFα (pg/ml) TGFα (pg/ml) 30 C TGFα (pg/ml) ** ** 35 TACE siRNA A HaCaT cells Figure 5 LPA induces P2Y5- and TACE-dependent TGFa release and consequent EGFR transactivation in keratinocytes. (A) LPA-induced TGFa release from primary keratinocytes in a metalloprotease-dependent manner. Keratinocytes were treated with LPA (1-oleoyl, unless otherwise noted) or a phorbol ester, TPA (100 nM), in the presence or absence of a broad-spectrum metalloprotease inhibitor, SDZ 242–484 (10 mM) (**Po0.01, ***Po0.001). (B) LPA-induced TGFa release from mouse primary keratinocytes. Keratinocytes were treated with LPA (10 mM) containing different fatty acids (1-palmitoyl (16:0), 1-oleoyl (18:1) and 1-stearoyl (18:0) and 1-arachidonoyl (20:4)). TGFa in the conditioned media was measured by sandwich ELISA (*Po0.05, **Po0.01 versus vehicle treatment). (C) Immunoblot analyses of EGFR and ERK phosphorylation in primary keratinocytes. Cells were treated with LPA or EGF (100 ng/ml) for 5 min (p-EGFR) or 15 min (p-ERK) in the presence or absence of SDZ 242–484 (10 mM) or an EGFR inhibitor, AG1478 (1 mM). (D) Expressions of LPA receptors in P4 dorsal hair follicles, primary keratinocyte and human HaCaT keratinocytes (n ¼ 4). The number of transcripts was normalized to Gapdh and the mean value of P2Y5 expression level was set at 1 (n ¼ 3–4). (E) Immunoblot analysis of siRNA-mediated knockdown of TACE in HaCaT cells. (F) TGFa release from siRNA-transfected HaCaT cells. Control, P2Y5 or TACE-knockdown cells were treated with LPA (10 mM) or TPA (100 nM) and TGFa release was measured (**Po0.01, ***Po0.001). Note that knockdown efficiency (mRNA reduction level quantified by qRT–PCR) of TACE siRNA and P2Y5 siRNA was 76±4.5% (mean±s.d., n ¼ 3) and 67±4.8%, respectively. (G, H) LPA analogues (10 mM) were tested for TGFa-releasing activities from primary keratinocytes (D) and HaCaT cells (E). The TGFa concentration in vehicle-treated cells was set as the baseline. Note that TGFa release was potently induced by P2Y5 agonists (XY31, XY36 and OMPT), but not by LPA analogues that lack P2Y5-agonistic activity (XY28 and T10). The structures and agonistic activities of these LPA analogues at LPA receptors are shown in Supplementary data. (A, B, F, G, H) Data are representative of three independent experiments and show the mean±s.d. of at least triplicate cultures. induced TGFa release and the consequent EGFR transactivation in keratinocytes. Reconstitution of LPA-induced TGFa release in HEK293 cells As a further test of whether P2Y5 has a role in TGFa release, we reconstituted a cell-based system that mimics ectodomain shedding of TGFa by utilizing an alkaline phosphatase (AP)tagged TGFa (AP-TGFa) (Tokumaru et al, 2000), which we refer to as an AP-TGFa shedding assay (Figure 6A). In this system, AP-TGFa release into the conditioned media can be quantitatively measured by a colorimetric reaction using p-nitrophenylphosphate (p-NPP). When HEK293 cells transiently expressing AP-TGFa and P2Y5 (either mouse P2Y5 or human P2Y5) were treated with LPA, AP activity was dose 4254 The EMBO Journal VOL 30 | NO 20 | 2011 dependently increased in the conditioned media (Figure 6B), showing that P2Y5 mediated LPA-induced AP-TGFa release. P2Y5-expressing cells and mock-transfected (control) cells were equally sensitive to TPA stimulation (Figure 6C), indicating that expression of P2Y5 did not affect PKC-induced AP-TGFa release. Importantly, no significant AP-TGFa release was induced from P2Y5-expressing cells by the other six lysophospholipids (Figure 6C; Supplementary Figure S8A), confirming that P2Y5 is an LPA-specific receptor. We noticed that a small amount of AP-TGFa was also released from control cells, possibly via endogenously expressed LPA receptors in HEK293 cells (Supplementary Figure S7). Indeed, siRNA-mediated knockdown of P2Y5 endogenously expressed in HEK293 cells attenuated LPA-induced AP-TGFa release by 45%, but did not attenuate TPA-induced AP-TGFa & 2011 European Molecular Biology Organization LPA-induced EGFR transactivation in hair follicles A Inoue et al AP activity on cell surface AP-TGFα AP activity in conditioned media (%) Total AP activity (100%) A AP activity in conditioned media Lysophospholipid Transfer conditioned media add p-NPP solution Proteinase HEK293 cell P2Y5 C mP2Y5 Control 20 AP activity release (%) AP activity release (%) hP2Y5 ** ** ** 15 ** 10 ** ** * 5 ** ** 0 0 10 100 LPA (nM) 1000 mP2Y5 LPA LPC LPE *** AP activity release (%) LPA α-tubulin P2Y5 HEK293 cells TPA H AP activity release (%) 25 NS 20 15 10 5 0 Inhibitor Vehicle NF449 NS PTX YM Y27632 U73122 LPA ** Ro NS 45 40 ** 10 5 0 LPA TPA *** *** *** Control P2Y5 Control LPA Control vector NS *** Control siRNA P2Y5 siRNA P2Y5 TPA J P2Y5 vector NS 5 NS I Control vector Treatment TPA *** *** Treatment AP activity release (%) Treatment 50 40 30 20 10 0 Vector TACE S1P LPS Control siRNA TACE siRNA AP activity release (%) Control siRNA *** LPI G NS 50 *** 40 *** 30 20 *** 10 0 Vector Control P2Y5 Control LPG AP activity release (%) 10 Control ** ** F Vehicle SDZ 242–484 hP2Y5 TACE siRNA E D 45 40 35 20 15 10 5 0 15 0 Treatment Vehicle Lysophospholipid pro-AP-TGFα AP activity release (%) B AP-TGFα pro-AP-TGFα TPA p - Nitrophenol p - NPP Proteinase Colorimetric reaction (OD405) P2Y5 p - Nitrophenol p - NPP 20 20 P2Y5 vector AP-TGFα LPA TACE * 15 ** P2Y5 ** 10 G12 G13 5 0 Vector Control DN G12 DN G13 DN RhoA Treatment RhoA pro-AP-TGFα PKC ROCK LPA Figure 6 LPA induces P2Y5- and TACE-dependent TGFa release via a G12/13–RhoA–ROCK pathway in HEK293 cells. (A) Scheme of AP-tagged (AP-TGFa) shedding assay. HEK293 cells transiently expressing AP-TGFa and P2Y5 were treated with a compound for 1 h. Amount of AP-TGFa release was quantified by measuring AP activities in both conditioned media and cell surface using a colorimetric reaction of AP substrate, p-NPP. Note that protease that cleaves AP-TGFa is endogenously expressed in HEK293 cells. AP activity detected in vehicle treatment was set as the baseline. (B) LPA induces AP-TGFa release from P2Y5-expressing cells. HEK293 cells that were transfected with mouse P2Y5 (mP2Y5), human P2Y5 (hP2Y5) or control vector were stimulated with 3–1000 nM of LPA (n ¼ 4; *Po0.05, **Po0.01 versus control cells). (C) Same as (B), but treated with various lysophospholipids (1 mM) and TPA (100 nM). Note that five lysophospholipids other than LPA did not induce P2Y5-dependent AP-TGFa release. Also note that transient expression of P2Y5 did not affect TPA (100 nM)-induced AP-TGFa release. (D) siRNA-mediated knockdown of P2Y5 endogenously expressing in HEK293 cells attenuated LPA-induced, but not TPA-induced, AP-TGFa release. Note that knockdown efficiency (mRNA reduction level quantified by qRT–PCR) with P2Y5 siRNA was 85±1.8% (mean±s.d., n ¼ 3). (E–G) SDZ 242–484 (a metalloprotease inhibitor; 1 mM) (E) or siRNA-mediated knockdown of TACE (F, G) inhibited both LPA (1 mM)-induced and TPA (100 nM)-induced AP-TGFa release. Note that knockdown efficiency with TACE siRNA was 90±0.7% (mean±s.d., n ¼ 3). (H) LPA/ P2Y5-induced AP-TGFa release was blocked by Y27632 (a ROCK inhibitor; 10 mM; 30 min pretreatment, unless otherwise noted) and Ro31-8425 (Ro; a pan-PKC inhibitor; 10 mM), but not by NF449 (a Gs inhibitor, 100 mM), PTX (a Gi inhibitor; 100 ng/ml; 16 h), YM254890 (YM; a Gq inhibitor; 10 mM) and U73122 (a PLCb inhibitor; 3 mM). (I) LPA/P2Y5-induced AP-TGFa release was blocked by co-transfection of DN forms of G proteins including G12, G13 (heterotrimeric Ga proteins) and RhoA (small G protein). Concentration of LPA was 1 mM (H, I). Bars and error bars in (C–E, G–I) represent mean values and s.d., respectively (n ¼ 3–4; *Po0.05, **Po0.01, ***Po0.001; NS, not significant difference). (J) Scheme of signal transduction leading to TGFa release in HEK293 cells. Upon binding of LPA, P2Y5 activates G12/13–RhoA–ROCK signalling, which leads to TACE-dependent ectodomain shedding of pro-TGFa, partially through a PKC pathway, and results in TGFa release. release (Figure 6D). Similar to TGFa release from keratinocytes, both LPA-induced and TPA-induced AP-TGFa release from HEK293 cells was almost completely suppressed by knockdown of TACE and pretreatment with a broad metalloprotease inhibitor, SDZ 242–484 (Figure 6E–G). Using the reconstituted model, we further examined signal transduction & 2011 European Molecular Biology Organization of P2Y5 leading to AP-TGFa release in HEK293 cells. Among four inhibitors that specifically block four distinct subclasses of heterotrimeric Ga proteins (Gs, Gi, Gq and G12/13), only Y27632 (a Rho kinase (ROCK) inhibitor; G12/13 pathway) inhibited LPA/P2Y5-induced AP-TGFa release, whereas NF449 (a Gs inhibitor), Pertussis Toxin (PTX; a Gi inhibitor) The EMBO Journal VOL 30 | NO 20 | 2011 4255 LPA-induced EGFR transactivation in hair follicles A Inoue et al manner via hydrolysis of PA on the plasma membrane and production of LPA. and YM254890 (a Gq inhibitor) did not have the inhibitory effect (Figure 6H). In addition, Ro31-8425 (a pan-PKC inhibitor), but not U73122 (a PLCb inhibitor), blocked LPA/ P2Y5-induced AP-TGFa release. Co-transfection of dominantnegative (DN) forms of G proteins including G12, G13 and RhoA also inhibited LPA/P2Y5-induced AP-TGFa release (Figure 6I), confirming the involvement of G12/13 signalling. Thus, we concluded that LPA/P2Y5-induced G12/13 signalling underlies TACE-dependent TGFa release (Figure 6J). Discussion Genetic studies of human hair disorders have suggested that LPA signalling has a crucial role in hair follicle development. However, the underlying molecular mechanism, even the involvement of LPA itself, has until now been unclear. The data presented here show that LPA generated by an LPAproducing enzyme, PA-PLA1a, regulates hair follicle formation through a mechanism that involves TGFa release and EGFR transactivation via the most recently identified LPA receptor, P2Y5 (Figure 8). This model is supported by the following observations: (i) PA-PLA1a/ mice exhibited a wavy hair phenotype that resembles the hair phenotype of mutant mice defective in TGFa-related genes (TACE, TGFa and EGFR) (Luetteke et al, 1993, 1994; Mann et al, 1993; Peschon et al, 1998; Hassemer et al, 2010); (ii) PA-PLA1a, TACE, TGFa and p-EGFR were co-expressed in the IRS and, PA-PLA1a and P2Y5 showed similar hair cycle-dependent expression; (iii) the activation states of TGFa and EGFR were decreased in PA-PLA1a/ mice; (iv) LPA species with unsaturated fatty acids, which were found to be potent agonists for P2Y5, were selectively lowered in PA-PLA1a/ mice; (v) LPA induced TGFa release and EGFR transactivation via P2Y5 and TACE in keratinocytes; and (vi) LPA and PAPLA1a induced P2Y5-mediated TGFa release in a TACE-dependent manner in reconstituted HEK293 cells. In vitro studies have demonstrated that LPA is an initiator of EGFR transactivation in a variety of cells such as corneal epithelial cells and lung epithelial cells (Prenzel et al, 1999; Zhao et al, 2006; Xu et al, 2007). This study is the first to demonstrate the in vivo significance of LPA-induced EGFR transactivation. Moreover, GPCR-induced EGFR transactivation has been PA-PLA1a initiates P2Y5-mediated TGFa release in HEK293 cells We finally asked whether PA-PLA1a itself is capable of inducing P2Y5-mediated AP-TGFa release. Co-expression of P2Y5 and PA-PLA1a, but not a catalytically inactive PA-PLA1a mutant (S154A) (Sonoda et al, 2002), dramatically enhanced AP-TGFa release (Figure 7A). A small but significant APTGFa release was observed when PA-PLA1a vector was introduced alone (Figure 7A, control þ WT), probably via endogenously expressed LPA receptors in HEK293 cells (Supplementary Figure S7), as was observed in LPA-stimulated mock-transfected cells (Figure 6B and D). Next, we tested whether PA-PLA1a was capable of activating P2Y5 in a juxtacrine manner. When PA-PLA1a-expressing cells and P2Y5-expressing cells were prepared separately and mixed together, significant AP-TGFa release from P2Y5-expressing cells was observed (Figure 7B). The AP-TGFa release was also dependent on the catalytic activity of PA-PLA1a and the transfection of the P2Y5 vector. The PA-PLA1a-initiated APTGFa release from P2Y5-expressing cells was further elevated upon treatment with bacterial phospholipase D (PLD) (Figure 7C), which was previously shown to generate PA on the outer leaflet of plasma membrane (Sonoda et al, 2002; Aoki, 2004). These data clearly show that PA-PLA1a is capable of activating P2Y5 in an autocrine and/or juxtacrine A B C pro-AP-TGFα PA-PLA1α pro-AP-TGFα PA-PLA1α P2Y5 pro-AP-TGFα PA-PLA1α P2Y5 P2Y5 PA PA AP activity release (%) 6 # ** ** ** 4 * 2 P2Y5 + WT P2Y5 + S154A Control + WT Control + S154A ## ## ** ** ** 0 AP activity release (%) P2Y5 + WT P2Y5 + S154A Control + WT Control + S154A 8 8 6 ** ** ** 4 * 2 AP activity release (%) PLD P2Y5 + WT P2Y5 + S154A Control + WT Control + S154A 25 20 ** * 15 10 5 0 0 0 10 100 1000 10 000 PA-PLA1α-expression vector (pg per well) 0 1 10 100 3 PA-PLA1α-expressing cells (×10 cells per well) 0 1 10 100 1000 Actinomadura PLD (mU/ml) Figure 7 PA-PLA1a induces P2Y5-dependent TGFa release. PA-PLA1a-mediated activation of P2Y5 in autocrine (A) and paracrine (B, C) manners. (A) Spontaneous AP-TGFa release from HEK293 cells expressing catalytically active PA-PLA1a (WT), P2Y5 and AP-TGFa. Note that AP-TGFa release was not observed in cells expressing catalytically inactive PA-PLA1a mutant harbouring a serine-to-alanine substitution at residue 154 (S154A). Also note that AP-TGFa release was significantly reduced when P2Y5 vector was replaced with an empty vector (control) (n ¼ 4; *Po0.05, **Po0.01 versus control vector-transfected cells; #Po0.05, ##Po0.01 versus S154A-expressing cells). (B) PA-PLA1a-induced paracrine activation of P2Y5. P2Y5- and AP-TGFa-expressing cells were mixed with PA-PLA1a-expressing cells that were separately prepared (n ¼ 4; *Po0.05, **Po0.01 versus control vector-transfected cells and S154A-expressing cells). (C) Exogenous phospholipase D (PLD) potently enhanced the PA-PLA1a-mediated AP-TGFa release. Same as B (2 103 PA-PLA1a-expressing cells per well), but in the presence of bacterial PLD. AP activity in the absence of PA-PLA1a-expressing cells and PLD treatment was used as the baseline (n ¼ 4; *Po0.05, **Po0.01 versus control vector-transfected cells and S154A-expressing cells). 4256 The EMBO Journal VOL 30 | NO 20 | 2011 & 2011 European Molecular Biology Organization LPA-induced EGFR transactivation in hair follicles A Inoue et al PA-PLA1α PA 2-acyl-LPA PA-PLA1α TACE PA P2Y5 TGFα pro-TGFα EGFR Inner root sheath Hair follicle development Figure 8 Proposed model for PA-PLA1a- and P2Y5-mediated hair follicle development. PA-PLA1a is expressed and secreted in the developing IRS of hair follicles and produces 2-acyl-LPA from PA on the outer leaflet of the plasma membrane by hydrolyzing the acyl chain at the sn-1 position. The resulting 2-acyl-LPA activates P2Y5 in a paracrine and/or autocrine manner, eliciting TACE-dependent shedding of membrane-bound TGFa (pro-TGFa). Soluble TGFa binds to EGFR in the IRS of hair follicles. Activated/phosphorylated EGFR induces development of the IRS, which is required for proper formation of the hair shaft. Genetic deletions of these molecules (PA-PLA1a in this study and Kazantseva et al (2006), P2Y5 (Pasternack et al, 2008; Shimomura et al, 2008), TACE (Peschon et al, 1998; Hassemer et al, 2010), TGFa (Luetteke et al, 1993; Mann et al, 1993), EGFR (Luetteke et al, 1994)) result in aberrant hair formation in mice and/or humans. implicated in several pathophysiological conditions such as renal lesions (Lautrette et al, 2005), wound healing (mediated by AT1) (Yahata et al, 2006), cardiac hypertrophy (AT1 and b1) (Zhai et al, 2006; Noma et al, 2007) and regulation of blood pressure (endothelin-1 receptors) (Chansel et al, 2006). However, these previous studies examined disease models that were, in most cases, induced by exogenously administered GPCR agonists. Thus, our data provide the first evidence of the physiological role of GPCR-induced EGFR transactivation in vivo. Recent experiments with mouse embryonic fibroblasts suggest that LPA signalling shares a common pathway with EGFR signalling (Stortelers et al, 2008). Because LPA-induced EGFR transactivation can be mediated by not only P2Y5 but also by other LPA receptors such as LPA1 and LPA3 (Supplementary Figure S10B and C), it is reasonable to assume that LPA-producing enzymes and LPA receptors may cooperatively function in EGFR transactivation, thereby affecting other EGFR-involved physiological and pathophysiological conditions such as wound healing, development of heart and bone and progression of cancer (Sibilia and Wagner, 1995; Threadgill et al, 1995). Activity of ADAMs is regulated by several kinases mainly through phosphorylation of a cytoplasmic region of these proteases in some systems (Mezyk et al, 2003; Edwards et al, 2008). These kinases are activated downstream of both receptor tyrosine kinases and GPCRs. Although some G proteins such as Gi and Gq are implicated in activation of ADAMs and consequent EGFR ligand release (Ohtsu et al, 2006; Uchiyama et al, 2009), little is known about G proteins involved in TACE activation. Our data establish a G12/ 13–RhoA–ROCK pathway, induced by LPA/P2Y5, as a novel regulator of TACE activation (Figure 6H–J). It should be noted that, consistent with our observation, Yanagida et al (2009) also showed that P2Y5 coupled with G13 and induced Rho & 2011 European Molecular Biology Organization signalling pathway. In general, G12/13 signalling, compared with Gs, Gi and Gq signalling, is considered an experimentally difficult pathway to detect in conventional GPCR assays such as cAMP, Ca2 þ mobilization and promoter-driven luciferase (Siehler, 2009). Our results suggest that AP-TGFa release may be a useful readout, which may uncover previously unidentified or unappreciated GPCRs coupled with G12/13. So far physiological importance of 2-acyl-LPA has not been elucidated. The present study demonstrated for the first time that 2-acyl-LPA is present in hair follicles and has a critical and specific role in hair follicle formation. Using the LC-MS/ MS method established in this study, we demonstrated that the levels of 2-acyl-LPA species with unsaturated fatty acids were reduced in PA-PLA1a/ hair follicles (Figure 2A–C), which demonstrates that PA-PLA1a produces 2-acyl-LPA in vivo. Thus, it seems likely that 2-acyl-LPA species with unsaturated fatty acids act as ligands of P2Y5 in hair follicles. In agreement with this, we found that P2Y5 was more strongly activated by LPA species with unsaturated fatty acids than by LPA species with saturated fatty acids (Supplementary Figure S8C). We previously showed that 2-acyl-LPA with unsaturated fatty acids preferentially activated LPA3 (Bandoh et al, 2000), which has a critical role in embryo implantation in the uterus (Ye et al, 2005). Together with these previous studies on LPA3, the present study on PA-PLA1a and P2Y5 underscores the importance of 2-acyl-LPA in regulating physiological events. It is likely that 2-acyl-LPA generated on a membrane by PA-PLA1a immediately acts on P2Y5 in an autocrine and/or juxtacrine manner. This model is supported by the following observations: (i) PA-PLA1a is a secreted membrane-bound enzyme (Sonoda et al, 2002) and is concentrated on the plasma membrane (Hiramatsu et al, 2003); (ii) PA-PLA1 a-expressing cells (Figure 7A and B), but not the conditioned media from the cells (data not shown), efficiently induced P2Y5-mediated AP-TGFa release in an autocrine or juxtacrine manner; and (iii) both PA-PLA1a (Figure 3G) and P2Y5 (Shimomura et al, 2008) are expressed in the IRS of the hair follicles. This model is also supported by the fact that 2acyl-LPA is generally unstable due to a reaction known as spontaneous acyl migration. Furthermore, the fact that PA-PLA1a directly activated P2Y5 indicates that PA is located in the outer leaflet of the plasma membrane and, more importantly, PA transporter/scramblase exists, similar to a recently identified PS scamblase (Suzuki et al, 2010), because PA is intracellularly synthesized. PA-PLA1a belongs to the lipase family, which includes pancreatic lipase and lipoprotein lipase. PA-PLA1a, together with PA-PLA1b and PS-specific PLA1 (PS-PLA1), form a subfamily within the lipase family. Unlike other lipases, these PLA1s exhibit strict substrate specificity to either PA (PA-PLA1a and b) (Sonoda et al, 2002; Hiramatsu et al, 2003) or PS (PS-PLA1) (Sato et al, 1997; Aoki et al, 2007). Our recent studies (paper in preparation) indicate that PS-PLA1 produces in vivo LPS, another lysophospholipid mediator with a variety of biological functions (Aoki et al, 2007; Makide et al, 2009). It is noteworthy that a unique feature of the products of these enzymes is that they have a fatty acid attached at the sn-2 position of the glycerol backbone. Our results show that 2-acyl-LPA is a potent ligand of P2Y5. Thus, from biochemical and structural points of view, we speculate The EMBO Journal VOL 30 | NO 20 | 2011 4257 LPA-induced EGFR transactivation in hair follicles A Inoue et al that an ancestral member of the lipase family that had a specific role in production of lysophospholipid mediators, such as LPA and LPS, emerged and evolved through gene duplication, which eventually formed the PLA1 subfamily. Materials and methods Reagents, antibodies and plasmids See Supplementary data. Animals Mice were maintained according to the Guidelines for Animal Experimentation of Tohoku University and the protocol was approved by the Institutional Animal Care and Use Committee at Tohoku University (No. 21-Pharm-Animal-21). Generation of PA-PLA1a/ mice is described in Supplementary data. In all experiments using homozygous mice, littermates were used for a control. Histology and in situ hybridization analyses See Supplementary data. Immunofluorescent staining Paraformaldehyde-fixed tissues were embedded in OTC compound (Sakura Finetek) or in paraffin wax. For paraffin sections, antigen retrieval was performed using 10 mM citrate buffer (pH 7.0) at 1201C for 10 min. PA-PLA1a was detected using biotinylated anti-PAPLA1a monoclonal antibody (clone mask1), followed by ABC Elite kit (Vector Laboratories) and TSA Alexa Fluor 488 kit (Invitrogen). Except for anti-PA-PLA1a monoclonal antibody, primary antibodies were visualized with secondary antibodies conjugated to Alexa Fluor 488, 568, 594 and 647. Nuclei were counterstained with 40 , 6-diamidino-2-phenylindole (DAPI). Fluorescent images were captured with a Zeiss LSM700 confocal microscope (Carl Zeiss). Quantitative RT–PCR analysis See Supplementary data. The primers used in the qRT–PCR analysis are listed in Supplementary data. Isolation of epidermal keratinocytes and dorsal hair follicles See Supplementary data. Cell culture and transfection See Supplementary data. Quantification of endogenous TGFa release from keratinocytes The media of primary mouse epidermal keratinocytes and HaCaT cells were replaced with 250 ml of supplement-free K-SFM and serum-free DMEM, respectively, on the day of cell stimulation. One hour later, primary keratinocytes were treated with various compounds for 2 h. For metalloprotease inhibitor treatment, cells were pretreated with 10 mM SDZ 242–484 for 30 min. TGFa levels in conditioned media were measured with a TGFa sandwich ELISA (human TGFa DuoSet Kit, R&D Systems) according to the manufacturer’s instructions. The TGFa sandwich ELISA kit can recognize murine TGFa. Immunoblot and immunoprecipitation See Supplementary data. Determination of soluble TGFa in hair follicles Vibrissa hair follicles were surgically isolated from P15 C57BL6/J mice by removing the collagen capsules in ice-cold PBS containing 1 mM EDTA and 10 mM SDZ 242–484 (see also Supplementary Figure S4A). Ten vibrissa hair follicles per a single mouse were extracted with a MS-100R beads cell disrupter in lysis buffer (25 mM HEPES (pH 7.3), 250 mM sucrose, 10 mM MgCl2, 1 mM EDTA, 10 mg/ml PMSF, 20 mg/ml leupeptin and 10 mM SDZ 242–484). Lysate was centrifuged at 1000 g for 10 min. The supernatant was centrifuged at 200 000 g for 30 min. Protein concentration in the resulting supernatant (soluble fraction) was measured with a Micro BCA Protein Assay Kit (Pierce) and an equal amount of protein was used for TGFa sandwich ELISA. Quantification of lysophospholipids by LC-MS/MS See Supplementary data. 4258 The EMBO Journal VOL 30 | NO 20 | 2011 AP-TGFa shedding assay AP-TGFa release was assayed by the previously described method (Tokumaru et al, 2000) with several modifications. HEK293 cells transiently expressing AP-TGFa with or without P2Y5 were detached with 0.05% Trypsin/0.52 mM EDTA, resuspended in Hank’s balanced salt solution (HBSS) containing 5 mM HEPES (pH 7.4), and seeded in 90 ml at 2 104 cells per well in a 96-well plate. After 30 min, cells were treated with 10 ml of 10 concentration of compounds for 1 h. After transferring 80 ml of conditioned media in each well to a new 96-well plate, 80 ml of p-NPP solution (10 mM p-NPP, 20 mM Tris–HCl (pH 9.5), 20 mM NaCl, 5 mM MgCl2) was added to both conditioned media and cells. OD405 was measured before and after 1 h incubation at 371C with a VersaMax microplate reader (Molecular Devices). AP activity release was calculated from the increase of OD405 during 1 h incubation in the conditioned media (DODmedia) and the cell (DODcell) as follows (also see Figure 7A): AP activity in the conditioned media (APmedia) (%) is defined as the ratio of DODmedia to total DOD values (DODmedia plus DODcell); AP activity release (%) is determined by subtracting basal APmedia from APmedia in the presence of a compound where basal APmedia is defined as APmedia in the absence of a compound. Note that basal APmedia varied from 5 to 12%, depending on assay conditions. For autocrine PA-PLA1a-initiated AP-TGFa release, HEK293 cells were transfected with combinations of PA-PLA1a, P2Y5 and APTGFa vectors in 100 ml of Opti-MEM (GIBCO) at 2 104 cells per each 96 well. Twenty-four hours after transfection, AP activity release was determined as described above. For paracrine PA-PLA1a-initiated AP-TGFa release, P2Y5 and AP-TGFa-expressing cells were prepared and seeded in a 96-well plate as described above. PA-PLA1a-expressing HEK293 cells were resuspended in HBSS and added to P2Y5 and AP-TGFa-expressing cells. After 1 h of incubation at 371C, AP activity release was determined. For exogenous PLD treatment, 2 104 of P2Y5 and AP-TGFaexpressing cells and 2 104 of PA-PLA1a-expressing cells were mixed and incubated for 1 h in the presence or absence of bacterial PLD. AP activity release was determined. Catalytically inactive PAPLA1a mutant (S154A) and empty vector were used as negative controls for PA-PLA1a and P2Y5, respectively. Statistics Columns and error bars represent means and standard deviations of independent experiments, respectively, unless otherwise indicated. Student’s t-test was used to determine the significance of differences between groups. One-way ANOVA with Bonferroni’s posttest analyses of multiple groups was employed for analyses of multiple groups. For all statistical tests, the 0.05 level of confidence was accepted for statistical significance. Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org). Acknowledgements We thank Dr Hitoshi Okochi and Dr Aki Osada (National Center for Global Health and Medicine, Japan) for technical advice on hair follicle analyses. JA was supported by grants from the National Institute of Biomedical Innovation, the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Science, Sports and Culture of Japan (MEXT) and PRESTO from Japan Science and Technology Corporation. IA was a research fellow of the Japan Society for the Promotion of Science (DC1 1811607). IA was supported by a Grant-in-Aid for Young Scientists (B) (KAKENHI 21790058), Takeda Science Foundation and The Naito Science & Engineering Foundation. GDP thanks the Human Frontier of Science Program and the NIH (NS29632) for financial support. Author contributions: AI, NA and JI performed the experiments and analysed the data. GDP developed LPA analogues. AI and JA prepared the paper. HA and JA supervised the work. Conflict of interest The authors declare that they have no conflict of interest. & 2011 European Molecular Biology Organization LPA-induced EGFR transactivation in hair follicles A Inoue et al References Anliker B, Chun J (2004) Lysophospholipid G protein-coupled receptors. J Biol Chem 279: 20555–20558 Aoki J (2004) Mechanisms of lysophosphatidic acid production. Sem Cell Dev Biol 15: 477–489 Aoki J, Inoue A, Makide K, Saiki N, Arai H (2007) Structure and function of extracellular phospholipase A1 belonging to the pancreatic lipase gene family. Biochimie 89: 197–204 Aoki J, Inoue A, Okudaira S (2008) Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 1781: 513–518 Aoki J, Taira A, Takanezawa Y, Kishi Y, Hama K, Kishimoto T, Mizuno K, Saku K, Taguchi R, Arai H (2002) Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 277: 48737–48744 Bandoh K, Aoki J, Taira A, Tsujimoto M, Arai H, Inoue K (2000) Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett 478: 159–165 Chansel D, Ciroldi M, Vandermeersch S, Jackson LF, Gomez AM, Henrion D, Lee DC, Coffman TM, Richard S, Dussaule JC, Tharaux PL (2006) Heparin binding EGF is necessary for vasospastic response to endothelin. FASEB J 20: 1936–1938 Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J (2010) LPA receptors: subtypes and biological actions. Ann Rev Pharmacol Toxicol 50: 157–186 Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH (2010) International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev 62: 579–587 Creer MH, Gross RW (1985) Separation of isomeric lysophospholipids by reverse phase HPLC. Lipids 20: 922–928 Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A (1997) Signal characteristics of G protein-transactivated EGF receptor. EMBO J 16: 7032–7044 Edwards DR, Handsley MM, Pennington CJ (2008) The ADAM metalloproteinases. Mol Aspects Med 29: 258–289 Hassemer EL, Le Gall SM, Liegel R, McNally M, Chang B, Zeiss CJ, Dubielzig RD, Horiuchi K, Kimura T, Okada Y, Blobel CP, Sidjanin DJ (2010) The waved with open eyelids (woe) locus is a hypomorphic mouse mutation in Adam17. Genetics 185: 245–255 Hiramatsu T, Sonoda H, Takanezawa Y, Morikawa R, Ishida M, Kasahara K, Sanai Y, Taguchi R, Aoki J, Arai H (2003) Biochemical and molecular characterization of two phosphatidic acid-selective phospholipase A1s, mPA-PLA1alpha and mPAPLA1beta. J Biol Chem 278: 49438–49447 Ishii S, Noguchi K, Yanagida K (2009) Non-EDG family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat 89: 57–65 Kanda H, Newton R, Klein R, Morita Y, Gunn MD, Rosen SD (2008) Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol 9: 415–423 Kaufman CK, Zhou P, Pasolli HA, Rendl M, Bolotin D, Lim KC, Dai X, Alegre ML, Fuchs E (2003) GATA-3: an unexpected regulator of cell lineage determination in skin. Genes Dev 17: 2108–2122 Kazantseva A, Goltsov A, Zinchenko R, Grigorenko AP, Abrukova AV, Moliaka YK, Kirillov AG, Guo Z, Lyle S, Ginter EK, Rogaev EI (2006) Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH. Science 314: 982–985 Kikkawa Y, Oyama A, Ishii R, Miura I, Amano T, Ishii Y, Yoshikawa Y, Masuya H, Wakana S, Shiroishi T, Taya C, Yonekawa H (2003) A small deletion hotspot in the type II keratin gene mK6irs1/ Krt2–6 g on mouse chromosome 15, a candidate for causing the wavy hair of the caracul (Ca) mutation. Genetics 165: 721–733 Koike S, Keino-Masu K, Ohto T, Sugiyama F, Takahashi S, Masu M (2009) Autotaxin/lysophospholipase D-mediated LPA signaling is required to form distinctive large lysosomes in the visceral endoderm cells of the mouse yolk Sac. J Biol Chem 284: 33561–33570 Kottirsch G, Koch G, Feifel R, Neumann U (2002) Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme. J Med Chem 45: 2289–2293 & 2011 European Molecular Biology Organization Langbein L, Rogers MA, Praetzel S, Winter H, Schweizer J (2003) K6irs1, K6irs2, K6irs3, and K6irs4 represent the innerroot-sheath-specific type II epithelial keratins of the human hair follicle. J Invest Dermatol 120: 512–522 Langbein L, Rogers MA, Praetzel-Wunder S, Helmke B, Schirmacher P, Schweizer J (2006) K25 (k25irs1), k26 (k25irs2), k27 (k25irs3), and k28 (k25irs4) represent the type I inner root sheath keratins of the human hair follicle. J Invest Dermatol 126: 2377–2386 Lautrette A, Li S, Alili R, Sunnarborg SW, Burtin M, Lee DC, Friedlander G, Terzi F (2005) Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nat Med 11: 867–874 Luetteke NC, Phillips HK, Qiu TH, Copeland NG, Earp HS, Jenkins NA, Lee DC (1994) The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 8: 399–413 Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC (1993) TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73: 263–278 Makide K, Kitamura H, Sato Y, Okutani M, Aoki J (2009) Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol. Prostaglandins Other Lipid Mediat 89: 135–139 Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AR (1993) Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73: 249–261 Mezyk R, Bzowska M, Bereta J (2003) Structure and functions of tumor necrosis factor-alpha converting enzyme. Acta Biochim Polonica 50: 625–645 Mills GB, Moolenaar WH (2003) The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3: 582–591 Moolenaar WH, van Meeteren LA, Giepmans BN (2004) The ins and outs of lysophosphatidic acid signaling. Bioessays 26: 870–881 Noma T, Lemaire A, Naga Prasad SV, Barki-Harrington L, Tilley DG, Chen J, Le Corvoisier P, Violin JD, Wei H, Lefkowitz RJ, Rockman HA (2007) Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest 117: 2445–2458 Ohtsu H, Dempsey PJ, Eguchi S (2006) ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol 291: C1–10 Pasternack SM, von Kugelgen I, Aboud KA, Lee YA, Ruschendorf F, Voss K, Hillmer AM, Molderings GJ, Franz T, Ramirez A, Nurnberg P, Nothen MM, Betz RC (2008) G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat Genet 40: 329–334 Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA (1998) An essential role for ectodomain shedding in mammalian development. Science 282: 1281–1284 Peters T, Sedlmeier R, Bussow H, Runkel F, Luers GH, Korthaus D, Fuchs H, Hrabe de Angelis M, Stumm G, Russ AP, Porter RM, Augustin M, Franz T (2003) Alopecia in a novel mouse model RCO3 is caused by mK6irs1 deficiency. J Invest Dermatol 121: 674–680 Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A (1999) EGF receptor transactivation by G-proteincoupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884–888 Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP (2004) Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164: 769–779 Sato T, Aoki J, Nagai Y, Dohmae N, Takio K, Doi T, Arai H, Inoue K (1997) Serine phospholipid-specific phospholipase A that is secreted from activated platelets. A new member of the lipase family. J Biol Chem 272: 2192–2198 Schweizer J, Langbein L, Rogers MA, Winter H (2007) Hair follicle-specific keratins and their diseases. Exp Cell Res 313: 2010–2020 Shimomura Y, Wajid M, Ishii Y, Shapiro L, Petukhova L, Gordon D, Christiano AM (2008) Disruption of P2RY5, an orphan G proteinThe EMBO Journal VOL 30 | NO 20 | 2011 4259 LPA-induced EGFR transactivation in hair follicles A Inoue et al coupled receptor, underlies autosomal recessive woolly hair. Nat Genet 40: 335–339 Shimomura Y, Wajid M, Petukhova L, Shapiro L, Christiano AM (2009) Mutations in the lipase H gene underlie autosomal recessive woolly hair/hypotrichosis. J Invest Dermatol 129: 622–628 Sibilia M, Wagner EF (1995) Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269: 234–238 Siehler S (2009) Regulation of RhoGEF proteins by G12/13-coupled receptors. Br J Pharmacol 158: 41–49 Skoura A, Hla T (2009) Lysophospholipid receptors in vertebrate development, physiology, and pathology. J Lipid Res 50 (Suppl): S293–S298 Sonoda H, Aoki J, Hiramatsu T, Ishida M, Bandoh K, Nagai Y, Taguchi R, Inoue K, Arai H (2002) A novel phosphatidic acid-selective phospholipase A1 that produces lysophosphatidic acid. J Biol Chem 277: 34254–34263 Stortelers C, Kerkhoven R, Moolenaar WH (2008) Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling. BMC Genomics 9: 387 Suzuki J, Umeda M, Sims PJ, Nagata S (2010) Calcium-dependent phospholipid scrambling by TMEM16F. Nature 468: 834–838 Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, Noji S, Yatomi Y, Aoki J, Arai H (2006) Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 281: 25822–25830 Tanaka S, Miura I, Yoshiki A, Kato Y, Yokoyama H, Shinogi A, Masuya H, Wakana S, Tamura M, Shiroishi T (2007) Mutations in the helix termination motif of mouse type I IRS keratin genes impair the assembly of keratin intermediate filament. Genomics 90: 703–711 Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ, Magnuson T (1995) Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230–234 Tokumaru S, Higashiyama S, Endo T, Nakagawa T, Miyagawa JI, Yamamori K, Hanakawa Y, Ohmoto H, Yoshino K, Shirakata Y, Matsuzawa Y, Hashimoto K, Taniguchi N (2000) Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol 151: 209–220 4260 The EMBO Journal VOL 30 | NO 20 | 2011 Uchiyama K, Saito M, Sasaki M, Obara Y, Higashiyama S, Nakahata N (2009) Thromboxane A2 receptor-mediated epidermal growth factor receptor transactivation: involvement of PKC-delta and PKC-epsilon in the shedding of epidermal growth factor receptor ligands. Eur J Pharm Sci 38: 504–511 van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradere JP, Pettit TR, Wakelam MJ, Saulnier-Blache JS, Mummery CL, Moolenaar WH, Jonkers J (2006) Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 26: 5015–5022 Xu KP, Yin J, Yu FS (2007) Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor. Invest Ophthalmol Vis Sci 48: 636–643 Yahata Y, Shirakata Y, Tokumaru S, Yang L, Dai X, Tohyama M, Tsuda T, Sayama K, Iwai M, Horiuchi M, Hashimoto K (2006) A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation. J Biol Chem 281: 13209–13216 Yanagida K, Masago K, Nakanishi H, Kihara Y, Hamano F, Tajima Y, Taguchi R, Shimizu T, Ishii S (2009) Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6. J Biol Chem 284: 17731–17741 Ye X, Hama K, Contos JJ, Anliker B, Inoue A, Skinner MK, Suzuki H, Amano T, Kennedy G, Arai H, Aoki J, Chun J (2005) LPA3mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435: 104–108 Zhai P, Galeotti J, Liu J, Holle E, Yu X, Wagner T, Sadoshima J (2006) An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy. Circ Res 99: 528–536 Zhao Y, He D, Saatian B, Watkins T, Spannhake EW, Pyne NJ, Natarajan V (2006) Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases. J Biol Chem 281: 19501–19511 & 2011 European Molecular Biology Organization